India revises prices of six bulk drugs
India's National Pharmaceutical Pricing Authority has revised theprices of six bulk drugs, reports the Times of India, raising five and lowering one.
Betamethasone alcohol's price goes up from 190.47 rupees per gram to 224 rupees, betamethasone valerate's rises 179.05 rupees per gram to 212 rupees and betamethasone phosphate is up from 166.52 rupees per gram to 185 rupees. A major beneficiary will be Glaxo India, which makes all the varieties of betamethasone available in India, it is reported.
The price of lynestrol, made by Infar India Ltd, goes up from 68,300 rupees per kg to 79,044 rupees per kg.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze